GlaxoSmithKline (Spain)-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2021

  1. Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)

    Drugs

  2. REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

    Drugs, Vol. 81, Núm. 15, pp. 1763-1774

2016

  1. Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic copd spanish patients

    International Journal of COPD, Vol. 11, pp. 123-132